alexa Abstract | Study of liver function abnormalities during statin therapy in a tertiary care center

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The statins are the most effective and best-tolerated agents for treating dyslipidemia. They can reduce all elevated lipids and also modestly raises High density lipoprotein -Cholesterol levels. They can reduce fatal and nonfatal coronary heart disease events, stroke, and total mortality. An open labelled cross sectioned study was conducted in the Department of General Medicine Sree Balaji medical college and hospital , Chrompet during the period of August 2015 to January 2016 .In our study ,patients on Atorvastatin had incidence of 4% abnormal elevation of liver enzymes, and patients on Rosuvastatin had incidence of 2% abnormal elevation of liver enzymes. p value was not significant (p=1).Hence this study shows that statins do not cause significant liver dysfunction and can be safely prescribed for all cases of dyslipidemia.

To read the full article Peer-reviewed Article PDF image

Author(s): Sowmya P Muthiah N S Susshmitha R and Arvinth A


Statins, Dyslipidemia, Coronary heart disease, Liver enzymes, statin therapy

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us